OTC Vaginal Atrophy Treatment
Total Trials
10
As Lead Sponsor
As Collaborator
0
Total Enrollment
931
NCT01432470
Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2010
Completion: Jun 30, 2011
NCT01987804
Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women
Start: Jan 31, 2012
Completion: Jan 31, 2013
NCT01975129
A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin
Start: Sep 30, 2013
Completion: Feb 28, 2014
NCT02497547
An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy
Start: Oct 31, 2014
Completion: Jul 31, 2015
NCT04629885
Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms
Start: May 3, 2016
Completion: May 3, 2017
NCT03112395
Local Application of Combined Optical and Magnetic Stimulation (COMS) for Treatment of Chronic Wounds: Safety Evaluation
Phase: N/A
Start: Apr 25, 2017
Completion: Jun 4, 2020
NCT03998722
Evaluation of VagiVital® for Treatment of Vaginal Atrophy
Start: Jun 14, 2019
Completion: Jun 24, 2020
NCT04489290
Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis
Start: Feb 12, 2021
Completion: Feb 28, 2024
NCT06104098
A User Study With Vernivia® for Bacterial Vaginosis.
Start: Apr 1, 2021
Completion: Jul 22, 2021
NCT05012852
Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis
Start: Sep 30, 2021
Completion: Jun 30, 2022
Loading map...